Navigation Links
Absence of the SMG1 protein could contribute to Parkinson's and other neurological disorders
Date:10/30/2013

PHOENIX, Ariz. Oct. 30, 2013 The absence of a protein called SMG1 could be a contributing factor in the development of Parkinson's disease and other related neurological disorders, according to a study led by the Translational Genomics Research Institute (TGen).

The study screened 711 human kinases (key regulators of cellular functions) and 206 phosphatases (key regulators of metabolic processes) to determine which might have the greatest relationship to the aggregation of a protein known as alpha-synuclein, which has been previously implicated in Parkinson's disease. Previous studies have shown that hyperphosphorylation of the α-synuclein protein on serine 129 is related to this aggregation.

"Identifying the kinases and phosphates that regulate this critical phosphorylation event may ultimately prove beneficial in the development of new drugs that could prevent synuclein dysfunction and toxicity in Parkinson's disease and other synucleinopathies," said Dr. Travis Dunckley, a TGen Assistant Professor and senior author of the study.

Synucleinopathies are neurodegenerative disorders characterized by aggregates of α-synuclein protein. They include Parkinson's, various forms of dementia and multiple systems atrophy (MSA).

The study SMG1 Identified as a Regulator of Parkinson's disease-associated alpha-Synuclein Through siRNA Screening was published today in the journal PLOS ONE.

By using the latest in genomic technologies, Dr. Dunckley and collaborators found that expression of the protein SMG1 was "significantly reduced" in tissue samples of patients with Parkinson's and dementia.

"These results suggest that reduced SMG1 expression may be a contributor to α-synuclein pathology in these diseases," Dr. Dunckley said.

TGen collaborators in this study included researchers from Banner Sun Health Institute and Mayo Clinic Scottsdale.

Tissue samples were provided by the Banner Brain and Body Donation Program. The study was funded by the Arizona Parkinson's Disease Consortium, which includes Mayo Clinic Scottsdale, Sun Health Research Institute, Barrow Neurologic Institute, Banner Good Samaritan Medical Center, Arizona State University, and TGen.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Testosterone promotes reciprocity in the absence of competition
2. RI Hospital: Absence of specific enzyme in cartilage can lead to benign tumors in mice
3. Viable and fertile fruit flies in the absence of histone H3.3
4. The absence of elephants and rhinoceroses reduces biodiversity in tropical forests
5. How problems with an Alzheimers protein can jam up traffic in the brain
6. Proteins in one of the worlds main biodiesel plants have been mapped -- and it does not look good
7. Samurai sword protein makes strategic cuts in cell skeletons
8. Molecular biology: Designer of protein factories exposed
9. Berkeley Lab researchers get a detailed look at a DNA repair protein in action
10. Researchers capture images of open channel that moves proteins across cell membranes
11. A protein safeguards against cataracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2016)... Allemagne, March 14, 2016 ... - --> - Renvoi : image disponible ... --> --> DERMALOG, ... fournit de nouveaux lecteurs d,empreintes digitales pour l,enregistrement ... DERMALOG sera utilisé pour produire des cartes d,identité ...
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
(Date:3/3/2016)... 2016  2016FLEX, organized by FlexTech, a SEMI ... in flexible, hybrid and printed electronics. More than ... have gathered for short courses, technical session, exhibits, ... The Flex Conference celebrates its 15 th ... organizations, and universities contributing to the adoption of ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... biotechnology to help treat hormonal and stress related hair loss. With patent-pending formulas ... hearts of key opinion leaders in the medical and salon channels nationwide. ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... gather at Boston CEO 2016 on May 31st and June 1st at The ... forum for leading executives in the life sciences, offering exclusive access to key ...
(Date:5/3/2016)... - And Other Rising Companies ... Those Competitor Biologics  - Biosimilar Drug Producers ... ,  Who are the most important and ... their sales potentials? Discover, in our updated survey, organisations, ... and revenue forecasting. Visiongain,s new ...
Breaking Biology Technology: